Bill Guyer

580 total citations
11 papers, 445 citations indexed

About

Bill Guyer is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Bill Guyer has authored 11 papers receiving a total of 445 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 8 papers in Virology and 3 papers in Epidemiology. Recurrent topics in Bill Guyer's work include HIV/AIDS drug development and treatment (9 papers), HIV Research and Treatment (8 papers) and HIV/AIDS Research and Interventions (5 papers). Bill Guyer is often cited by papers focused on HIV/AIDS drug development and treatment (9 papers), HIV Research and Treatment (8 papers) and HIV/AIDS Research and Interventions (5 papers). Bill Guyer collaborates with scholars based in United States, United Kingdom and Spain. Bill Guyer's co-authors include Brian P. Kearney, Trevor Hawkins, Robert L. St. Claire, Vivian M. Yeh, Homayoun Khanlou, Anthony Mills, Will Garner, Kirsten White, David Piontkowsky and Keith Henry and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and The Lancet Infectious Diseases.

In The Last Decade

Bill Guyer

11 papers receiving 438 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bill Guyer United States	8	417	320	99	71	33	11	445
Ian McGowan United States	6	464 1.1×	362 1.1×	46 0.5×	108 1.5×	41 1.2×	11	492
Randall Tressler United States	7	219 0.5×	239 0.7×	90 0.9×	75 1.1×	34 1.0×	11	327
C Cohen United States	10	249 0.6×	176 0.6×	79 0.8×	80 1.1×	15 0.5×	18	321
S. Hammer United States	6	207 0.5×	182 0.6×	48 0.5×	40 0.6×	28 0.8×	9	271
Joseph J. Eron United States	5	261 0.6×	183 0.6×	45 0.5×	58 0.8×	8 0.2×	6	307
Greet Beets United States	6	364 0.9×	298 0.9×	35 0.4×	123 1.7×	40 1.2×	8	430
Radjin Steingrover Netherlands	11	381 0.9×	418 1.3×	135 1.4×	89 1.3×	20 0.6×	15	530
Anitha J. Cecelia India	9	262 0.6×	171 0.5×	46 0.5×	87 1.2×	21 0.6×	10	328
María José Rolón Argentina	9	288 0.7×	180 0.6×	50 0.5×	110 1.5×	32 1.0×	28	349
Annapaola Callegaro Italy	11	496 1.2×	426 1.3×	115 1.2×	132 1.9×	15 0.5×	24	588

Countries citing papers authored by Bill Guyer

Since Specialization

Citations

This map shows the geographic impact of Bill Guyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bill Guyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bill Guyer more than expected).

Fields of papers citing papers by Bill Guyer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bill Guyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bill Guyer. The network helps show where Bill Guyer may publish in the future.

Co-authorship network of co-authors of Bill Guyer

This figure shows the co-authorship network connecting the top 25 collaborators of Bill Guyer. A scholar is included among the top collaborators of Bill Guyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bill Guyer. Bill Guyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Huhn, Gregory, Moti Ramgopal, Mamta K. Jain, et al.. (2020). HIV/HCV therapy with ledipasvir/sofosbuvir after randomized switch to emtricitabine-tenofovir alafenamide-based single-tablet regimens. PLoS ONE. 15(1). e0224875–e0224875. 5 indexed citations

Tam, Edward, Anne F. Luetkemeyer, Parvez Mantry, et al.. (2017). Ledipasvir/sofosbuvir for treatment of hepatitis C virus in sofosbuvir‐experienced, NS5A treatment‐naïve patients: Findings from two randomized trials. Liver International. 38(6). 1010–1021. 11 indexed citations

Pozniak, Anton, Martin Markowitz, Anthony Mills, et al.. (2014). Switching to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus continuation of non-nucleoside reverse transcriptase inhibitor with emtricitabine and tenofovir in virologically suppressed adults with HIV (STRATEGY-NNRTI): 48 week results of a randomised, open-label, phase 3b non-inferiority trial. The Lancet Infectious Diseases. 14(7). 590–599. 75 indexed citations

Nelson, Mark, Richard Elion, C Cohen, et al.. (2013). Rilpivirine Versus Efavirenz in HIV-1–Infected Subjects Receiving Emtricitabine/Tenofovir DF: Pooled 96-Week Data from ECHO and THRIVE Studies. HIV Clinical Trials. 14(3). 81–91. 46 indexed citations

Campo, Rafael, E DeJesus, U. Fritz Bredeek, et al.. (2013). SWIFT: Prospective 48-Week Study to Evaluate Efficacy and Safety of Switching to Emtricitabine/Tenofovir From Lamivudine/Abacavir in Virologically Suppressed HIV-1 Infected Patients on a Boosted Protease Inhibitor Containing Antiretroviral Regimen. Clinical Infectious Diseases. 56(11). 1637–1645. 36 indexed citations

Miller, Michael D., et al.. (2012). Trends in HIV-1 Reverse Transcriptase Resistance-Associated Mutations and Antiretroviral Prescription Data from 2003–2010. Antiviral Therapy. 17(6). 993–999. 15 indexed citations

Cohen, Cal, José Ramón Arribas, Kenneth R. Henry, et al.. (2012). STAR Study: single tablet regimen emtricitabine/rilpivirine/tenofovir DF is non‐inferior to efavirenz/emtricitabine/tenofovir DF in ART‐naïve adults. Journal of the International AIDS Society. 15(S4). 1–1. 25 indexed citations

Scott, James, et al.. (2006). Serious Renal Impairment Occurs Rarely with Use of Tenofovir DF. HIV Clinical Trials. 7(2). 55–58. 7 indexed citations

Khanlou, Homayoun, et al.. (2005). Early Virologic Failure in a Pilot Study Evaluating the Efficacy of Therapy Containing Once-Daily Abacavir, Lamivudine, and Tenofovir DF in Treatment-Naive HIV-Infected Patients. AIDS Patient Care and STDs. 19(3). 135–140. 52 indexed citations

10.

Hawkins, Trevor, et al.. (2005). Intracellular Pharmacokinetics of Tenofovir Diphosphate, Carbovir Triphosphate, and Lamivudine Triphosphate in Patients Receiving Triple-Nucleoside Regimens. JAIDS Journal of Acquired Immune Deficiency Syndromes. 39(4). 406–411. 172 indexed citations

11.

Guyer, Bill & Gary M. Whitford. (1975). Oxolinic acid in urinary tract infection a multi-centre trial. Current Medical Research and Opinion. 2(10). 636–640. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact